Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-02-05, Stock:LLY, The news for the past five days is as follows:
2018-01-29: NEWS1: Alex Azar sworn in as secretary of Health and Human Services.NEWS2: Will Azar Practice 'Art of the Deal' Capitalism at Trump's HHS?.NEWS3: Alex Azar sworn in as secretary of Health and Human Services.NEWS4: Lilly (LLY) to Report Q4 Earnings: What's in the Cards?.NEWS5: You Definitely Should Buy Celgene Corporation Stock After Earnings Beat.NEWS6: PFE, LLY, MRK Write Up 'Scripts For Q4.NEWS7: Pfizer, Eli Lilly, Merck Earnings Preview: Big Pharma On Docket This Week.NEWS8: AbbVie (ABBV) Soars on Q4 Results: Key Takeaways from the Earnings Call.NEWS9: Lilly (LLY) to Report Q4 Earnings: What&apos;s in the Cards?.
2018-01-30: NEWS1: Drug/Biotech Stocks Q4 Earnings Due on Jan 31: LLY & VRTX.NEWS2: Eli Lilly’s 4Q17 Estimates: Human Pharmaceuticals Business.NEWS3: Pre-Market Earnings Report for January 31, 2018 :  BA, LLY, TMO, ANTM, EPD, ADP, SPG, JCI, SIRI, IR, ERIC, WEC.NEWS4: Eli Lilly’s 4Q17 Estimates: Revenue Growth Expected.NEWS5: Analysts’ Estimates for Eli Lilly’s 4Q17 Earnings.
2018-01-31: NEWS1: Dow Leads In Tight Finish; Video Gamers Clear Buy Points.NEWS2: Dow Leads In Tight Finish; Video Gamers Clear Buy Points.NEWS3: U.S. public health chief quits over financial conflicts.NEWS4: What Happened in the Stock Market Today.NEWS5: ADP, Q4, SOTU Boost Market.NEWS6: ADP, Q4, SOTU Boost Market.NEWS7: Lilly Issues Beat-And-Raise But Dives Alongside Other Drug Stocks.NEWS8: Lilly Issues Beat-And-Raise But Dives Alongside Other Drug Stocks.NEWS9: Expect more wild swings in the Dow in February: trader.NEWS10: Lilly Issues Beat-And-Raise But Dives Alongside Other Drug Stocks.NEWS11: Dow, S&P 500 and Nasdaq Finish Higher After Up-and-Down Day of Trading.NEWS12: Health Care Sector Update for 01/31/2018: BLCM,TMO,AMTM,LLY.NEWS13: Health Care Sector Update for 01/31/2018: BLCM,TMO,AMTM,LLY.NEWS14: Wednesday's ETF Movers: IYR, PJP.NEWS15: Wednesday's ETF Movers: IYR, PJP.NEWS16: Wednesday's ETF with Unusual Volume: MOAT.NEWS17: Wednesday's ETF with Unusual Volume: MOAT.NEWS18: Markets Rebound Bigly on ADP, Q4, SOTU.NEWS19: Markets Rebound Bigly on ADP, Q4, SOTU.NEWS20: Lilly (LLY) Beats on Q4 Earnings, Raises 2018 EPS Guidance.NEWS21: Lilly (LLY) Beats on Q4 Earnings, Raises 2018 EPS Guidance.NEWS22: Eli Lilly Beats Estimates, but Shares Head Lower Amid Diabetes Concerns.NEWS23: Health Care Sector Update for 01/31/2018: TMO,LLY,ANTM.NEWS24: Health Care Sector Update for 01/31/2018: TMO,LLY,ANTM.NEWS25: Lilly beats estimates; shares fall on diabetes, animal health concerns.NEWS26: Eli Lilly Earnings: What It Said to Sink Its Stock.NEWS27: Lilly beats estimates; shares fall on diabetes, animal health concerns.NEWS28: Markets Rebound Bigly on ADP, Q4, SOTU.NEWS29: AbbVie Is Ruining Pharma Earnings Season.NEWS30: US Stocks Rebound on Positive Earnings, Higher Real Estate Sector.NEWS31: US Stocks Rebound on Positive Earnings, Higher Real Estate Sector.NEWS32: Eli Lilly CEO Welcomes Amazon’s Arrival in the Health Care Business.NEWS33: Lilly (LLY) Beats on Q4 Earnings, Raises 2018 EPS Guidance.NEWS34: Stocks Close Modestly Higher Following Fed Announcement - U.S. Commentary.NEWS35: Stocks Close Modestly Higher Following Fed Announcement - U.S. Commentary.NEWS36: Analysts’ Ratings and Recommendations for Eli Lilly.NEWS37: Eli Lilly (LLY) Tops Q4 Earnings & Sales, Ups 2018 View.NEWS38: Eli Lilly (LLY) Tops Q4 Earnings & Sales, Ups 2018 View.NEWS39: Dow Gains 200 Points as Boeing Leads Stocks Higher.NEWS40: Dow Gains 200 Points as Boeing Leads Stocks Higher.NEWS41: Eli Lilly CEO Ready to Put $9 Billion in Cash to Work.NEWS42: Eli Lilly’s 4Q17 Estimates: Elanco.NEWS43: Health Care Sector Update for 01/31/2018: JNJ, PFE, ABT, MRK, AMGN, LLY, BLCM, ANTM, PLX, TMO, BGNE.NEWS44: Health Care Sector Update for 01/31/2018: JNJ, PFE, ABT, MRK, AMGN, LLY, BLCM, ANTM, PLX, TMO, BGNE.NEWS45: Eli Lilly Cruises Through Q4 Earnings.NEWS46: Is Celldex Therapeutics, Inc. (CLDX) a Buy?.NEWS47: Is Celldex Therapeutics, Inc. (CLDX) a Buy?.NEWS48: Eli Lilly CEO rebuffs Trump&apos;s attack on drug prices.NEWS49: Stocks making the biggest moves premarket: BA, ANTM, ADP, LLY, AVY, XRX, EA & more.NEWS50: Eli Lilly (LLY) Tops Q4 Earnings & Sales, Ups 2018 View.NEWS51: Eli Lilly’s 4Q17 Estimates: New Products Portfolio.NEWS52: Eli Lilly CEO: New products driving top line growth.NEWS53: Lilly reports 4Q loss.NEWS54: Major Averages Pull Back Off Best Levels But Remain Positive - U.S. Commentary.NEWS55: Major Averages Pull Back Off Best Levels But Remain Positive - U.S. Commentary.NEWS56: Earnings Reaction History: Eli Lilly & Co., 36.4% Follow-Through Indicator, 1.9% Sensitive.NEWS57: Eli Lilly falls 5 percent on sluggish growth in animal health, as it weighs options for the unit.NEWS58: Drugmaker Eli Lilly posts quarterly loss on tax charges.NEWS59: Lilly Reports Strong Fourth-Quarter and Full-Year 2017 Revenue Growth, Increases 2018 EPS Guidance.NEWS60: Eli Lilly And Co. Q4 17 Earnings Conference Call At 9:00 AM ET.NEWS61: Eli Lilly And Co. Q4 17 Earnings Conference Call At 9:00 AM ET.NEWS62: Lilly Lifts 2018 Profit View; Backs Revenue Outlook.NEWS63: Lilly Lifts 2018 Profit View; Backs Revenue Outlook.NEWS64: Eli Lilly And Co. Profit Rises In Q4.NEWS65: Eli Lilly And Co. Profit Rises In Q4.NEWS66: Drug/Biotech Stocks Q4 Earnings Due on Jan 31: LLY & VRTX.
2018-02-01: NEWS1: How’s Celgene’s Abraxane Positioned after 4Q17?.NEWS2: Johnson & Johnson’s Recent Developments.NEWS3: [$$] DowDuPont Unit Dumps GE Stock, Buys Ford.NEWS4: Merck’s 4Q17 Estimates: Vaccines.NEWS5: Johnson & Johnson’s 4Q17 Guidance for Fiscal 2018.NEWS6: What Happened in the Stock Market Today.NEWS7: What Happened in the Stock Market Today.
2018-02-02: NEWS1: Noteworthy ETF Inflows: XLV, JNJ, TMO, LLY.NEWS2: Noteworthy ETF Inflows: XLV, JNJ, TMO, LLY.NEWS3: Celgene: Pomalyst and Otezla’s Revenue Trends in 4Q17.NEWS4: Johnson & Johnson’s Valuation after Its 4Q17 Earnings.

Answer: Decrease